Octenidine

Octenidine

SCHEMBL986183

CCCCCCCCN=c1ccn(CCCCCCCCCCn2ccc(=NCCCCCCCC)cc2)cc1.CCCCCCCCN=c1ccn(CCCCCCCCCCn2ccc(=NCCCCCCCC)cc2)cc1.Cl.Cl

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Octenidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 known ✓ P07900 2/20 0.54
KCNA3 known ✓ P22001 3/20 0.36
PTGS1 known ✓ P23219 3/20 0.34
PTGS2 known ✓ P35354 3/20 0.34
NPC1 O15118 7/20 0.54
RAB9A P51151 7/20 0.54
HTT P42858 6/20 0.54
MAPK1 P28482 4/20 0.54
LMNA P02545 3/20 0.54
NPSR1 Q6W5P4 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
GALR3 O60755 2/20 0.54
POLB P06746 2/20 0.54
ATM Q13315 2/20 0.54
APOBEC3A P31941 2/20 0.54
APOBEC3G Q9HC16 2/20 0.54
MAPT P10636 2/20 0.54
KDM4E B2RXH2 1/20 0.54
RAD52 P43351 1/20 0.54
PAX8 Q06710 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Octenidine SCHEMBL8824299 1.00 NPC1 (0.54) NPC1RAB9AHTTMAPK1LMNA
Hydrochloric Acid SCHEMBL10573899 1.00 NPC1 (0.54) NPC1RAB9AHTTMAPK1LMNA
Octenidine SCHEMBL126751 1.00 NPC1 (0.54) NPC1RAB9AHTTMAPK1LMNA
Octenidine SCHEMBL126065 1.00 NPC1 (0.54) NPC1RAB9AHTTMAPK1LMNA
Hydrochloric Acid SCHEMBL10573221 1.00 NPC1 (0.54) NPC1RAB9AHTTMAPK1LMNA
Pirtenidine SCHEMBL10344101 1.00 NPC1 (0.54) NPC1RAB9AHTTMAPK1LMNA
Octenidine SCHEMBL16836483 1.00 NPC1 (0.54) NPC1RAB9AHTTMAPK1LMNA
SCHEMBL23393769 0.98 NPC1 (0.56) NPC1RAB9AHTTMAPK1LMNA
SCHEMBL10569601 0.98 NPC1 (0.56) NPC1RAB9AHTTMAPK1LMNA
SCHEMBL10570053 0.98 NPC1 (0.56) NPC1RAB9AHTTMAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1964581-B1 Surgical sewing material with antimicrobial surface and method for antimicrobial coating of surgical sewing material HERAEUS KULZER GMBH (DE) 2011-11-02 EP claimed
CN-101168071-B Surgical suture material with an antimicrobial surface and process for providing an antimicrobial coating on surgical suture material HERAEUS KULZER GMBH 2011-09-14 CN claimed
US-8012173-B2 Surgical suture material with an antimicrobial surface and process for providing an antimicrobial coating on surgical suture material HERAEUS KULZER GMBH (DE) 2011-09-06 US claimed
US-20110015673-A1 SURGICAL SUTURE MATERIAL WITH AN ANTIMICROBIAL SURFACE AND PROCESS FOR PROVIDING AN ANTIMICROBIAL COATING ON SURGICAL SUTURE MATERIAL HERAEUS KULZER GMBH (DE) 2011-01-20 US claimed
US-7829133-B2 Surgical suture material with an antimicrobial surface and process for providing an antimicrobial coating on surgical suture material HERAEUS KULZER GMBH (DE) 2010-11-09 US claimed
US-20080103526-A1 SURGICAL SUTURE MATERIAL WITH AN ANTIMICROBIAL SURFACE AND PROCESS FOR PROVIDING AN ANTIMICROBIAL COATING ON SURGICAL SUTURE MATERIAL HERAEUS KULZER GMBH (DE) 2008-05-01 US claimed
CN-101168071-A Surgical suture material with an antimicrobial surface and process for providing an antimicrobial coating on surgical suture material HERAEUS KULZER GMBH (DE) 2008-04-30 CN claimed
US-4206215-A Antimicrobial bis-[4-(substituted-amino)-1-pyridinium]alkanes STERLING DRUG INC. (US) 1980-06-03 US claimed
EP-2968401-B1 TINTED ANTISEPTIC SOLUTIONS HAVING IMPROVED STABILITY CAREFUSION 2200 INC (US) 2020-09-09 EP disclosed
US-10456227-B2 Methods of surface treating tubular medical products ENSION INC. (US) 2019-10-29 US disclosed
US-20180125620-A1 METHODS OF SURFACE TREATING TUBULAR MEDICAL PRODUCTS ENSION INC. 2018-05-10 US disclosed
US-9821066-B2 Tinted antiseptic solutions having improved stability CAREFUSION 2200, INC. (US) 2017-11-21 US disclosed
US-9693841-B2 Surface treated staples, sutures and dental floss and methods of manufacturing the same ENSION, INC. (US) 2017-07-04 US disclosed
EP-2968401-A1 TINTED ANTISEPTIC SOLUTIONS HAVING IMPROVED STABILITY CareFusion 2200 Inc. (US) 2016-01-20 EP disclosed
JP-2008104881-A SURGICAL SUTURE MATERIAL WITH ANTIMICROBIAL SURFACE AND PROCESS FOR PROVIDING ANTIMICROBIAL COATING ON SURGICAL SUTURE MATERIAL HERAEUS KULZER GMBH 2008-05-08 JP disclosed
US-20080103526-A1 SURGICAL SUTURE MATERIAL WITH AN ANTIMICROBIAL SURFACE AND PROCESS FOR PROVIDING AN ANTIMICROBIAL COATING ON SURGICAL SUTURE MATERIAL HERAEUS KULZER GMBH (DE) 2008-05-01 US disclosed
US-20080103526-A1 SURGICAL SUTURE MATERIAL WITH AN ANTIMICROBIAL SURFACE AND PROCESS FOR PROVIDING AN ANTIMICROBIAL COATING ON SURGICAL SUTURE MATERIAL HERAEUS KULZER GMBH (DE) 2008-05-01 US disclosed
CN-101168071-A Surgical suture material with an antimicrobial surface and process for providing an antimicrobial coating on surgical suture material HERAEUS KULZER GMBH (DE) 2008-04-30 CN disclosed
CN-101168071-A Surgical suture material with an antimicrobial surface and process for providing an antimicrobial coating on surgical suture material HERAEUS KULZER GMBH (DE) 2008-04-30 CN disclosed
US-4206215-A Antimicrobial bis-[4-(substituted-amino)-1-pyridinium]alkanes STERLING DRUG INC. (US) 1980-06-03 US disclosed